Why Retired Athletes Get Hit With Depression Years Later
Contact sport, remote hits, and treatment-resistant depression.
You knew the trade you were making. The hits, the collisions, the times you got your bell rung and jogged back to the huddle anyway. That was the price of the game, and you paid it. What nobody handed you on the way out was the small print: the fog that can settle in years or even decades after the last whistle. If you are a former contact-sport athlete carrying a heaviness that will not lift, and you have quietly wondered why nothing you have tried seems to touch it, this is worth reading slowly.
The Delay Is the Confusing Part
Most people expect the effects of a hard hit to show up right away, and then fade. Sometimes they do. But a large body of research now points to a longer arc. In one five-year follow-up of people who took a significant hit, roughly half were not back to their old baseline (TRACK-TBI, 5-year outcomes). The mood, the sleep, the drive: for many, it just never fully came back, and the gap between the injury and the symptoms was wide enough that nobody connected the two.
That gap is exactly why retired athlete depression so often gets misread. By the time the low mood arrives, the concussion is a distant memory, filed under "part of playing." So the depression gets treated as if it appeared out of nowhere, with no history behind it. The history matters, though. People with a bell-ringing hit are more than three times as likely to have depression, and that elevated risk persists for years (Beaton et al., 2020, Frontiers in Neurology).
When the Usual Medicines Do Not Land
Here is the part that tends to sting, because so many people have lived it. You did the responsible thing. You saw a doctor, you tried an antidepressant, maybe two or three. And the needle barely moved. That is not a personal failure, and it is not proof that you are "just not trying hard enough."
There may be a mechanical reason. A meta-analysis of antidepressants given after a head impact found no significant difference from placebo (Foreman et al., 2019, J Head Trauma Rehabil). Standard antidepressants are built to work on the serotonin system. But the kind of low mood that can follow an old head injury may run, at least in part, on a different system entirely: glutamate, the brain's primary excitatory messenger. If the depression is being driven down one road and the medicine is patrolling a different road, it can miss. That is one reason clinicians use the phrase treatment-resistant depression: the standard tools were tried in good faith and did not reach it.
Why It Is Rarely Just Mood
An old hit tends to leave a wider footprint than sadness alone, and the extra pieces are clues, not coincidences. When you look at the whole picture, patterns show up:
- Sleep that never recovered. Sleep disorders affect somewhere between roughly 30 and 70 percent of people with a head-injury history. Broken sleep alone can flatten mood, blunt motivation, and mimic depression on its own.
- Hormones running low. Up to about 1 in 6 people develop a hormone deficiency after a hit (pooled prevalence near 16.8 percent). Low testosterone or thyroid output can look exactly like depression, and it will not respond to an antidepressant because it was never a serotonin problem to begin with.
- The heaviness that outlasts everything. The mood symptoms that persist for years, long after the body healed, are often the loudest signal that something structural, not situational, is in play.
This is why the same handful of symptoms can have very different engines underneath. Sorting out which engine is running is a medical question, and it deserves a medical answer rather than another round of trial and error.
What Glutamate Has to Do With It
The reason the glutamate angle has drawn so much attention is speed and mechanism. Ketamine and esketamine act on the glutamate system, with effects that can be measured in hours rather than weeks, and they appear to open a neuroplasticity window in the range of 24 to 72 hours (Zanos and Gould, 2018, Molecular Psychiatry). That is a fundamentally different route than the one serotonin-based medicines take.
Two honest caveats belong right here, because they matter. First, an old head injury is a risk factor for treatment-resistant depression. It is not, by itself, a reason for any particular treatment. Second, Spravato (esketamine) is FDA-approved for treatment-resistant depression. It is not approved for concussion or for any head injury, and no responsible clinic will tell you otherwise. The point is narrower and calmer than a headline: if your depression has resisted the standard approach, the mechanism behind it is worth actually investigating.
If Things Have Gotten Dark
One more piece deserves plain, gentle language. Research has found elevated odds of death by suicide among people with a concussion history (Erlangsen et al., 2018, JAMA). If you are in that place right now, you are not weak and you are not alone in it. You can call or text 988 in the United States, any hour, and reach someone who will simply stay with you. Reaching out is not surrender. It is the same instinct that made you tough enough to play in the first place, pointed somewhere useful.
The Value of Someone Actually Looking
The thread running through all of this is that the depression carried by so many former athletes tends to get evaluated without its history. Nobody puts the old hits, the sleep, the hormones, and the treatment resistance on the same page. That is precisely where having neurology on staff earns its keep. It is a diagnostic lens, a way to ask why the standard care missed, not a promise of any specific outcome. It cannot undo the past. What it can do is help explain the present.
If any of this feels familiar, if you have spent years assuming the fog was just who you are now, a proper evaluation from a clinic that has neurology on staff can look at the whole picture and help make sense of it. You spent a long time absorbing hits so other people did not have to. It is a fair thing, after all that, to let someone finally look closely at you.
The connection between an old hit and today's depression is exactly what a clinic with neurology on staff is built to look at.
Spravato® (esketamine) is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. It is not FDA-approved for concussion, traumatic brain injury, or post-concussion syndrome. Use in patients with a concussion history is based on clinical judgment regarding the depression component. Off-label ketamine (IV, IM, oral) is not FDA-approved for any psychiatric indication. This page is educational and not medical advice. Individual results vary.